10
Participants
Start Date
May 31, 2019
Primary Completion Date
May 31, 2022
Study Completion Date
July 31, 2022
ExaBlate 4000
The Exablate 4000, an advanced, non-invasive technique for performing ablation of the Thalamus for treating Essential Tremor, received FDA PMA (P150038) approval for unilateral treatment of Essential Tremor in 2016.
Osaka University Hospital, Suita
Lead Sponsor
InSightec
INDUSTRY